JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A8736 THZ531

Target: Cyclin-Dependent Kinases

Summary: CDK12 and CDK13 covalent inhibitor

≥55.8 mg/mL
A8737 S63845
11 Citation

Target: MCL1

Summary: MCL1 inhibitor
A8738 TASIN-1

Summary: inhibitor of mutant adenomatous polyposis coli (APC)

≥35.2 mg/mL
A8739 CCT251545 analogue

Summary: Potent, Selective, orally bioavailable CDK 8/19 Inhibitor

≥20.7 mg/mL
B6079 VIP (human, rat, mouse, rabbit, canine, porcine)

insoluble in EtOH; ≥21.8 mg/mL
B6080 Methylthioadenosine

Summary: sulfur-containing nucleoside

≥83.33 mg/mL
B6081 BAY-598

Summary: SMYD2 inhibitor

Soluble in DMSO
B6082 EPZ031686

Summary: SMYD3 inhibitor

insoluble in H2O; insoluble in EtOH; ≥104.6 mg/mL
B6083 LiCl

Summary: used to precipitate RNA

insoluble in DMSO; insoluble in EtOH; ≥4.2 mg/mL
B6084 AS8351

Summary: histone demethylase inhibitor

≥29.1 mg/mL